Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| HTCO | High-Trend International Group | $23.50 | $12.25 | 108.89% | 6.5M | $83M | $4.55$61.75 |
| SGMT | Sagimet Biosciences | $8.58 | $2.72 | 46.42% | 1.2M | $191M | $3.03$11.41 |
| UCAR | U Power | $2.27 | $0.63 | 38.41% | 34.7M | $3.5M | $0.38$49.80 |
| MANE | Veradermics | $93.44 | $25.60 | 37.74% | 2.3M | $2.5B | $17.00$101.81 |
| EDSA | Edesa Biotech | $9.10 | $1.84 | 25.34% | 1.1M | $61M | $0.72$9.63 |
| QUIK | QuickLogic | $15.95 | $2.87 | 21.90% | 1.9M | $232M | $4.80$16.89 |
| RMAX | RE/MAX Holdings | $9.70 | $1.71 | 21.34% | 11.7M | $161M | $5.46$10.32 |
| QNTM | Quantum BioPharma Ltd. | $4.24 | $0.63 | 17.45% | 1.3M | $21M | $2.07$38.25 |
| OGN | Organon & Co. | $13.19 | $1.93 | 17.10% | 95M | $2.9B | $5.69$13.25 |
| ORKA | Oruka Therapeutics | $80.18 | $11.15 | 16.15% | 4.7M | $3.4B | $8.91$91.00 |
| ABSI | Absci | $4.55 | $0.61 | 15.48% | 5.5M | $603M | $2.24$5.23 |
| THRY | Thryv | $3.83 | $0.51 | 15.21% | 1.4M | $147M | $1.91$15.49 |
| REPL | Replimune Group | $2.77 | $0.35 | 14.26% | 3.1M | $200M | $1.50$13.24 |
| DWSN | Dawson Geophysical | $3.70 | $0.46 | 14.20% | 242.3K | $101M | $1.08$5.54 |
| CLIK | Click | $3.14 | $0.39 | 14.18% | 162.6K | $9.0M | $1.32$34.20 |
| ANAB | AnaptysBio | $66.84 | $7.96 | 13.52% | 618.6K | $1.7B | $11.40$70.22 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $11.06 | $1.31 | 13.44% | 239.4K | - | $3.99$15.25 |
| TRAK | ReposiTrak | $9.21 | $1.09 | 13.42% | 352K | $148M | $6.94$23.72 |
| EUDA | Euda Health | $12.04 | $1.42 | 13.37% | 7.5K | $27M | $5.26$86.00 |
| ANTX | An2 Therapeutics | $4.92 | $0.58 | 13.36% | 345.1K | $156M | $1.00$6.91 |
| YDDL | One And One Green Technologies. | $5.22 | $0.60 | 12.99% | 179.8K | $249M | $3.61$16.23 |
| GNLN | Greenlane | $4.52 | $0.51 | 12.72% | 41.7K | $2.5M | $2.09$101.40 |
| IMUX | Immunic | $9.88 | $1.07 | 12.20% | 272.8K | $1.1B | $5.06$15.10 |
| LACG | Themes ETF Trust - Leverage Shares 2x Long Lac Daily ETF | $10.71 | $1.15 | 11.97% | 8K | - | $6.34$26.22 |
| PN | Skycorp Solar Group | $2.66 | $0.28 | 11.77% | 62K | $34M | $2.18$87.40 |
Related Articles
Featured Article
Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True?
David Jagielski, CPA|Nov 21, 2023
High-yielding stocks may be tantalizing, but they often come with risks.
Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks.
David Jagielski, CPA|Jul 21, 2023
These stocks can significantly bolster your income.
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
David Jagielski, CPA|Jun 29, 2023
These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio.
Could the Owner of the Yellow Pages Be the Next Multibillion-Dollar SaaS Company?
Michael Byrne|Apr 12, 2022
Don't close the book on the Yellow Pages operator just yet.
3 of the Best Value Stocks to Buy Heading Into April
David Jagielski, CPA|Mar 30, 2022
With these shares at modest valuations, you can score some cheap long-term investments.
Should Investors Hold Out Hope for bluebird bio and Merck Spinoff Organon?
Keith Speights and Brian Orelli, PhD|Jul 10, 2021
Neither healthcare stock has performed well so far this year.
Learning From Stock Market Losers
Motley Fool Staff|Jan 14, 2021
Rule Breaker Investing: David's Biggest Losers Volume 6
2 Biotech Stocks That Could Have Tripled Your Money This Year
Cory Renauer|Nov 15, 2020
One has a better chance to keep climbing than the other does.
2 Top Biotech Stocks From the IPO Class of 2018 to Buy Now
Cory Renauer|Nov 4, 2020
Compelling clinical trial results so far make these biotech stocks worth more attention than they've received so far.
Better Buy: AnaptysBio vs. Exelixis
David Haen|Apr 24, 2020
Key clinical trial results this quarter will determine the better buy.
